title: Editorial Commentary: Pyogenic Vertebral Osteomyelitis and Antimicrobial Therapy: It's Not Just the Length, but Also the Choice.
authors.affiliation: Department of Infectious Diseases, Hospital Universitari de Bellvitge, IDIBELL, Barcelona.
authors.forename: Oscar
authors.initials: O
authors.lastname: Murillo
authors.affiliation: Unit of Infectious Diseases, Hospital Universitario 12 de Octubre, Instituto de Investigación 12 de Octubre, Madrid, Spain.
authors.forename: Jaime
authors.initials: J
authors.lastname: Lora-Tamayo
mesh_terms: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D004359:Drug Therapy, Combination; D006801:Humans; D008826:Microbial Sensitivity Tests; D010019:Osteomyelitis; D012293:Rifampin; D013203:Staphylococcal Infections; D013211:Staphylococcus aureus; D014640:Vancomycin
chemical_list: D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D014640:Vancomycin; D012293:Rifampin
keywords: methicillin-resistant Staphylococcus aureus; rifampin; spondylodiskitis; vancomycin